Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Psoriasis 2Pruritus 1Lymphoma, Follicular 1Congenital Abnormalities 1Autoimmune Diseases 1Arthritis, Psoriatic 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
apremilast × Clear all
NCT02775500 2025-01-28

Apremilast Pregnancy Exposure Registry

University of California, San Diego

Active not recruiting
233 enrolled

Congenital Abnormalities, Autoimmune Diseases, Psoriasis, Arthritis, Psoriatic

NCT03721172 2024-05-29

ADVANCE

Amgen

Phase 3 Completed
595 enrolled 19 charts
Lymphoid

Lymphoma, Follicular, Pruritus, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡